<DOC>
	<DOC>NCT00690378</DOC>
	<brief_summary>The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated urinary tract infections as compared to a comparator group.</brief_summary>
	<brief_title>Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Avibactam</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Acute pyelonephritis or other complicated urinary tract infection due to gram negative pathogens ileal loops or vesicoureteral reflux complete obstruction of any portion of urinary tract, perinephric or intrarenal abscess. fungal urinary tract infection permanent indirect catheter or nephrostomy unless removed within 48 hours of study entry history hypersensitivity to study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>